May 20, 2024 – Talk Bio

FDA Revokes Accelerated Approval of Helsinn’s Cancer Drug at Company’s Request

11 months ago talkbio0Tagged Accelerated, Antineoplastic Agents, Approved, Clinical Trials, Helsinn, patient safety, regulatory, United States Food and Drug Administration

FDA, Helsinn, accelerated approval, cancer drug, company request, drug withdrawal, regulatory decision, clinical trials, patient safety.

AstraZeneca Ordered to Pay Pfizer Over $107 Million in Tagrisso Patent Infringement Case

11 months ago talkbio0Tagged AstraZeneca, infringement, jury, Legal patent, Malignant neoplasm of lung, Pfizer, Tagrisso, Tissue damage

AstraZeneca, Pfizer, Tagrisso, patent infringement, jury verdict, damages, lung cancer treatment

Translarna by PTC Therapeutics: Awaiting Another EU Regulatory Review for Muscular Dystrophy Treatment

11 months ago talkbio0Tagged ataluren, disease treatment, EU, European Medicines Agency, factor IX, Infrequent, Muscular Dystrophy, Muscular Dystrophy, Duchenne, regulatory approval, Translarna

PTC Therapeutics, Translarna, muscular dystrophy, EU review, regulatory approval, Duchenne muscular dystrophy (DMD), European Medicines Agency (EMA), ataluren, rare disease treatment.

Legislators Profit from Bill Restricting Chinese Biotech Firms

11 months ago talkbio0Tagged China, Conflict (Psychology), Congress (U.S. Legislature), financial gain, Influence, legislative, trading

Congress, stock trading, China biotech ban, financial gain, legislative influence, conflict of interest.

Moderna Secures Victory in EU Patent Dispute with Pfizer-BioNTech over COVID-19 Vaccine

11 months ago talkbio0Tagged BioNTech, COVID19 (disease), Drug Industry, EPO, EU, European (ethnic group), Intellectual Property, Legal patent, Moderna, mRNA technology, Pfizer, Vaccines

Moderna, Pfizer, BioNTech, EU, patent dispute, COVID-19 vaccine, mRNA technology, European Patent Office (EPO), intellectual property rights, pharmaceutical industry.

Revolutionizing Drug Discovery: The Evolution from Target-Selective Design to AI-Powered Polypharmacology

11 months ago talkbio0Tagged AI-enabled, Drug Discovery, Machine Learning, multi-target, Polypharmacology, Precision Medicine, Systems Biology, Target-Selective Design

Drug Discovery, Target-Selective Design, AI-Enabled Polypharmacology, Machine Learning, Systems Biology, Multi-Target Drugs, Personalized Medicine.

AstraZeneca Invests $1.5 Billion in Singapore for State-of-the-art Antibody-Drug Conjugate Manufacturing Facility

11 months ago talkbio0Tagged Antibody-Drug Conjugates, AstraZeneca, Biotechnology, Cancer Therapeutic Procedure, end-to-end, expansion, Facility (object), Generalized, innovation, Investments, Singapore

AstraZeneca, Singapore, investment, antibody-drug conjugate (ADC), manufacturing facility, end-to-end production, biotechnology, pharmaceuticals, cancer treatment, innovation, global expansion.